| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |